scholarly journals A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses

2014 ◽  
Vol 74 (6) ◽  
pp. 1261-1270 ◽  
Author(s):  
E. E. W. Cohen ◽  
M. Tortorici ◽  
S. Kim ◽  
A. Ingrosso ◽  
Y. K. Pithavala ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Long Term Outcomes ◽  
Advanced Thyroid Cancer ◽  
Histologic Subtypes

Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumors: updated analysis of an Australian multicenter phase II trial.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e16056-e16056
Author(s):  
Peter S. Grimison ◽  
Martin R. Stockler ◽  
Andrew James Martin ◽  
Luke Buizen ◽  
Nicola Jane Lawrence ◽  
...  
Keyword(s):  
Germ Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Germ Cell Tumors ◽  
Long Term Outcomes ◽  
Multicenter Phase

Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 6557-6557 ◽  
Author(s):  
D. Rizzieri ◽  
K. Stockerl-Goldstein ◽  
A. Wei ◽  
R. H. Herzig ◽  
F. Erlandsson ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Long Term Outcomes ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document